OMP Achieves Top Two Rankings in Four Use Cases in the 2025 Gartner Critical Capabilities for Supply Chain Planning Solutions Report
ANTWERPEN, BE / ACCESS Newswire / May 6, 2025 / OMP, a global leader in supply chain planning solutions, has achieved four second-highest scores across five Use Cases, evaluated in the 2025 Gartner® Critical Capabilities for Supply Chain Planning Solutions report. This report, a companion to the Gartner Magic Quadrant™, assesses the vendors of the SCP solutions evaluated in this research.
This recognition follows OMP's recent position as highest on the Ability to Execute axis in the 2025 Gartner Magic Quadrant for Supply Chain Planning Solutions - marking the tenth consecutive time OMP is named a Leader.
Consistent strength across real-world planning challenges
The Critical Capabilities report evaluates 20 vendors on 15 key capabilities across five SCP Use Cases. We believe OMP's scores, particularly in supply planning, decision/plan alignment, and the breadth of resource types, demonstrate its strong performance in these critical areas.
"Supply chains today need real solutions that deliver measurable impact, and this report validates our ability to do just that," says Philip Vervloesem, Chief Commercial & Markets Officer at OMP. "Unison Planning™ stands out in end-to-end multi-enterprise planning and decision/plan alignment, two capabilities essential in today's fast-moving landscape. It enables smart, fast, and unified decision-making in complex environments."
Unison PlanningTM: enabling real-time, data-driven decisions
OMP's Unison Planning™ is an open, cloud-native, and AI-driven platform that supports supply chain planning across all layers, from strategic to operational, and from supply to demand. Designed for agility and resilience, it enables real-time collaboration, optimization, and response.
"By embedding generative AI and explainable AI (XAI) into every layer of the platform - from data-driven forecasting to scenario management - we empower planners to adapt with speed and intelligence," adds Tom Wouters, Chief Product Officer at OMP."
Proven performance, global trust
"We believe recognition in both the Magic Quadrant and the Critical Capabilities reports underscores our ability to execute and to deliver real business value," concludes Kurt Gillis, Chief Industry & Commercial Officer at OMP. "It reflects our deep industry expertise, which allows us to develop real solutions for industry-specific challenges. We're proud to help global leaders across industries turn complexity into a competitive edge."
Gartner, Critical Capabilities for Supply Chain Planning Solutions, Pia Orup Lund, et. Al, 14 April 2025.
Gartner, Magic Quadrant for Supply Chain Planning Solutions, Pia Orup Lund, et. Al, 14 April 2025
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Contact Information
Philip Vervloesem
Chief Commercial & Markets Officer
pvervloesem@omp.com
+1-770-956-2723
SOURCE: OMP
View the original press release on ACCESS Newswire
OMP
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Global Survey Reveals Urgent Gaps in Awareness, Access, and Treatment for Hepatitis D6.5.2025 08:00:00 CEST | Press release
LONDON, UK / ACCESS Newswire / May 6, 2025 / A new report released today by the World Hepatitis Alliance (WHA) reveals widespread knowledge gaps, inequities in access, and critical systemic barriers impeding the global fight against hepatitis delta. Also known as hepatitis D, hepatitis delta is a severe liver disease affecting an estimated 12 million people worldwide. It occurs in people living with hepatitis B, leads to faster disease progression, and significantly increases the risk of liver cancer and death. The Hepatitis Delta Global Landscape Survey collected responses from 583 individuals across 102 countries, providing the most comprehensive picture to date of global stakeholder perspectives on awareness, testing, and treatment access around hepatitis delta. Key Findings: There are pronounced regional variations in reported availability and accessibility of hepatitis delta testing and treatment. Even where hepatitis delta testing and treatment are reported to be available, acces
Camino Announces Exploration Results at Los Chapitos and Further Exploration Plans in Peru6.5.2025 06:00:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / May 6, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) (WKN: A116E1) ("Camino" or the "Company") is pleased to announce exploration results at its Copper-Silver stratabound Los Chapitos copper project ("Los Chapitos" or the "Project"), including drilling and additional mapping, trenching, and sampling along both the La Estancia and Diva copper mineralized trends. The Company is targeting large-scale disseminated manto-type copper-silver mineralization to support resource delineation studies at Los Chapitos. Camino and its partner Nittetsu Mining Co., Ltd. ("Nittetsu") plan to commence the next phase of drilling in the second half of 2025. The Los Chapitos copper project is located near the coastal city of Chala in the department of Arequipa in Peru. Juan Carlos Castelli, Consulting Geologist from Chile, said "the Los Chapitos property is inside the northern continuation of the metallogenic Cu-Ag belt defined in Northern Chile, with operat
Black Iron Congratulates the U.S. and Ukraine on Their Minerals Deal and Aims to Help Pave the Way With Its Highly Advanced Ukraine New Mining Project5.5.2025 07:16:00 CEST | Press release
U.S. and Ukraine entered into a landmark agreement to jointly develop Ukraine's vast mineral resources. Black Iron (TSX:BKI) is developing the most advanced project to construction in Ukraine. Black Iron's successful construction and operation will create a development roadmap for investments under the U.S. - Ukraine Minerals Agreement. TORONTO, ON / ACCESS Newswire / May 5, 2025 / Black Iron Inc. ("Black Iron" or the "Company") (TSX:BKI)(OTCPK:BKIRF)(FWB:BIN) congratulates Ukraine and the United States governments on signing a landmark agreement to jointly develop Ukraine's vast mineral resources - a strategic move designed to accelerate post-war reconstruction and reduce global dependency on hostile-state supply chains. With potentially trillions of dollars worth of untapped mineral resources and growing Western support, Ukraine is positioning itself as a future powerhouse in the critical minerals sector. The challenge is that there hasn't been a new large-scale mine constructed in U
Northway Biotech Launches Full-Service Viral Clearance Studies, Delivering Results Faster Than Industry Standards5.5.2025 06:45:00 CEST | Press release
With six newly established, identical BSL-2 laboratories now operational, biologics CDMO Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks VILNIUS, LT / ACCESS Newswire / May 5, 2025 / Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), today announced the expansion of its protein-based and gene therapy service offerings with the addition of Viral Clearance Studies (VCS) capabilities. This strategic growth follows the opening of Northway Biotech's new Gene Therapy Center with dedicated cGMP facilities for virus-related projects. With six newly established, identical BSL-2 laboratories now operational, Northway Biotech can conduct VCS programs for up to six clients simultaneously, significantly alleviating current market bottlenecks. Additionally, the company has expanded its capabilities to perform GMP-compliant manufacturing and testing under BSL-3 condition
BioNxt Solutions Reports Expanded Patent Protection from the Eurasian Patent Organization5.5.2025 03:05:00 CEST | Press release
VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that its first national level patent filing has been accepted by the Eurasian Patent Organization (EAPO). The EAPO has confirmed the Company‘s core patent claims, namely: novelty, inventive step, and industrial applicability. BioNxt's flagship patent filing, which received a positive international examination report from the European Patent Office, reported September 9, 2024, is a comprehensive patent application for sublingual delivery of anticancer drugs for the treatment of autoimmune neurodegenerative diseases. This patent family provides numerous proprietary product development and commercialization opportunities, including BioNxt's lead product, BNT23001, a sublingual thin-film formulation of Cladribine for the treatment of multiple sclerosis (MS). The EA
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom